Clarifying both PNPLA2-dependent and -independent roles of ABHD5 in prostate cancer may uncover new insights into how lipid metabolism intersects with oncogenic signaling pathways such as c-MYC. This evidence concerns the gene PNPLA2 and prostate carcinoma.